VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$35.57
+0.84 (+2.42%)
As of May 9, 1:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
254.71M
Net Income
15.23M
Gross Margin
74.4%
Profit Margin
6.0%
Rev Growth
+18.9%
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 254.71M 214.24M 156.14M 179.63M
Gross Profit 189.55M 159.43M 99.49M 114.46M
Operating Income 10.19M 7.71M 41.33M 44.36M
Net Income 15.23M 11.53M 35.53M 31.27M
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Rev Growth +18.9% +18.9% +24.7% +19.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.85M 4.85M 622.73M 660.37M
Total Equity 850.29M 850.29M 997.81M 1.08B
D/E Ratio 0.01 0.01 0.62 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 20.79M 16.61M 44.60M 53.31M
Free Cash Flow 32.60M 24.70M